A Double-Blind, Double-Dummy, Prospective, Randomized Multiple-Site Study of Oral Finafloxacin 300 mg b.i.d. Versus Oral Ciprofloxacin 250 mg b.i.d. in Patients With Lower Uncomplicated UTI (uUTI) With a Treatment Duration of 3 Days.

Trial Profile

A Double-Blind, Double-Dummy, Prospective, Randomized Multiple-Site Study of Oral Finafloxacin 300 mg b.i.d. Versus Oral Ciprofloxacin 250 mg b.i.d. in Patients With Lower Uncomplicated UTI (uUTI) With a Treatment Duration of 3 Days.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2015

At a glance

  • Drugs Ciprofloxacin; Finafloxacin
  • Indications Bacterial infections; Urinary tract infections
  • Focus Therapeutic Use
  • Acronyms FLUT
  • Most Recent Events

    • 21 Sep 2015 Pooled analysis results from this trial and an another trial presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
    • 30 Apr 2012 Planned number of patients changed from 36 to 48 as reported by European Clinical Trials Database.
    • 30 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2007-007742-35).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top